AICARM News January 2026: Three-Year Strategic Plan 2026–2028 and 2026 Program Plan, authorized centers at Mavacamten, webinars on prevention, longevity and cardiomyopathies, cardio-oncology, new YouTube channel and informational events.

For AICARM, December is a time for assessment, growth, and new goals. In this newsletter: the Association's birthday, stories from patients and families, clinical updates, masterclasses, and solidarity initiatives.

This month, AICARM on aicarm news. Let's help reduce the waiting list times of the national health system, we talk about youth hardship and gliflozins.

This month, AICARM reports on the success of the Ragusa conference, the strength of the network between patients and doctors, and the upcoming conference "The Heart of Women," dedicated to gender medicine and female awareness in the treatment of cardiomyopathies.

From the voices of Listening Hearts volunteers Marina and Valerio, to insights into artificial intelligence and gender medicine, the AICARM newsletter explores emotions, innovation, and new challenges in the diagnosis and treatment of cardiomyopathies.

In this AICARM newsletter: the first Italian regional law to prevent sudden cardiac death, upcoming training courses, the documentary film Un Cuore Grande presented at the Giffoni Film Festival, and support initiatives for patients and families.

AICARM's 2025 summer newsletter features a wide range of content dedicated to patients with cardiomyopathy and their families. The issue opens with the good news of the resolution of the shortage of Ritmodan (disopyramide), an essential drug for hypertrophic obstructive cardiomyopathy.

AICARM NEWS: Updates on patient rights, testimonials, webinars, courses, and initiatives for living with cardiomyopathy safely and with awareness.

AICARM NEWS of May The May 2025 newsletter of AICARM APS reports the results of the Annual Assembly and the future programs of the association. Among the topics covered: the approval of the budget, the first aid training projects, the promotion of 5x1000, the excellence in the treatment of cardiomyopathies, the importance of the Mediterranean diet for heart health, and the webinar on nutrition with Dr. Sara Farnetti. New dates are also available for the BLSD courses and the 2024 Annual Report.

AICARM NEWS of April The Italian Medicines Agency has reported the shortage of the drugs Ritmodan 100 and Ritmodan Retard 250, essential for the treatment of arrhythmias and also used in patients with hypertrophic obstructive cardiomyopathy. As has already happened in the past with Nadolol, AICARM has intervened promptly by collaborating with AIFA and the cardiology societies to monitor the situation, indicate alternative strategies and reduce the inconvenience for patients and doctors. The official AIFA press release with the methods of administration of Ritmodan 100 is available on the AICARM website. This edition also recounts the experience of “Pedalando con il Cuore”, an e-bike tour in the Crete Senesi, described by participants as a moment of rebirth and sharing. There is also space for the testimony of journalist Piero Meucci and the column by Niccolò Maurizi on the sense of guilt linked to the genetic transmission of heart disease.